Literature DB >> 9428727

NG108-15 cells express neuregulin that induces AChR alpha-subunit synthesis in cultured myotubes.

S Pun1, J F Yang, Y P Ng, K W Tsim.   

Abstract

A cholinergic neuroblastoma x glioma hybrid cell line NG108-15 is able to form functional synapses, and contains both AChR-aggregating and AChR-inducing activities when cocultured with myotubes. Several lines of evidence indicate that the AChR-inducing activity of NG108-15 cells is derived from neuregulin. The conditioned medium of cultured NG108-15 cells induced the expression of AChR alpha-subunit as well as the tyrosine phosphorylation of erbB-3 receptor. NG108-15 cells expressed neuregulin with a protein of approximately 100 kDa in size and transcripts of approximately 6.8 kbp, approximately 2.6 kbp and approximately 1.8 kbp; mRNAs encoding beta1 and alpha2 isoforms of neuregulin were revealed. NG108-15 cells were induced to differentiate by chemicals, and the chemical-induced differentiation of NG108-15 cells increased the level of neuregulin mRNA expression approximately 3-fold while the expression of a housekeeping gene remained relatively unchanged. The activity of neuregulin in the conditioned medium of NG108-15 cells was reduced by treating the medium with heparin and anti-neuregulin antibody. In addition, NG108-15 cells were transfected with antisense neuregulin cDNA and its expression of neuregulin was reduced, while its neuregulin-induced tyrosine phosphorylation activity was markedly decreased. This is the first direct demonstration that the NG108-15 cell-induced AChR upregulation on cultured myotubes is mediated by neuron-derived neuregulin.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9428727     DOI: 10.1016/s0014-5793(97)01369-0

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  1 in total

1.  Role for calcium-activated potassium channels (BK) in growth control of human malignant glioma cells.

Authors:  Amy K Weaver; Xiaojin Liu; Harald Sontheimer
Journal:  J Neurosci Res       Date:  2004-10-15       Impact factor: 4.164

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.